Clinical Neurology and Neurosurgery
Volume 111, Issue 10 , Pages 883-885, December 2009

Ziprasidone-related oculogyric crisis in an adult

  • Bernardo de Mattos Viana

      Affiliations

    • Psychiatry Service, Hospital das Clínicas (HC-UFMG), Federal University of Minas Gerais, Av. Alfredo Balena, 110, Santa Efigênia, Belo Horizonte (MG), 30130-100, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 31 34099458; fax: +55 31 34099458.
  • ,
  • Hugo Alejandro Cano Prais

      Affiliations

    • Department of Medical Sciences, Federal University of Ouro Preto, Ouro Preto (MG), Brazil
  • ,
  • Sarah Teixeira Camargos

      Affiliations

    • Movement Disorders Clinic, Neurology Service, Hospital das Clínicas (HC-UFMG), Federal University of Minas Gerais, Belo Horizonte (MG), Brazil
    • Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte (MG), Brazil
  • ,
  • Francisco Eduardo Costa Cardoso

      Affiliations

    • Movement Disorders Clinic, Neurology Service, Hospital das Clínicas (HC-UFMG), Federal University of Minas Gerais, Belo Horizonte (MG), Brazil
    • Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte (MG), Brazil

Received 23 December 2008; received in revised form 16 July 2009; accepted 25 July 2009.

Abstract 

Introduction

Drug-induced dyskinesias are common side-effects of first-generation antipsychotics (FGAs) but are not usually related to second-generation antipsychotics (SGAs). Oculogyric crisis (OGC) is a disabling acute dystonia that affects extra-ocular muscles usually resulting in an upward deviation of the eyes, which lasts from minutes to hours.

Case report

We describe an adult patient, previously exposed to an FGA, who developed OGC on 80mg/day of ziprasidone. The movement disorder significantly improved after use of 1mg/day of clonazepam without the need to switch to another SGA.

Discussion

The clinical features of the movement disorder of our patient meet the criteria for OGC. It is, sometimes, difficult to directly correlate a drug-induced dyskinesia to a SGA due to previous exposures to FGAs. The onset of OGC after exposure to ziprasidone without simultaneous use of other antipsychotic suggests a casual relationship between the former and the movement disorder. It is possible that previous use of an FGA was a risk factor for the development of OGC.

Conclusion

To the best of our knowledge, this is the first report of ziprasidone-related OGC in an adult patient. Physicians must be aware of its occurrence in order to improve care of patients treated with these agents.

Keywords: Oculogyric crisis, Ziprasidone, Tardive dyskinesia, Acute dystonia, Drug-induced dyskinesia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0303-8467(09)00187-5

doi:10.1016/j.clineuro.2009.07.015

Clinical Neurology and Neurosurgery
Volume 111, Issue 10 , Pages 883-885, December 2009